| Product Name | Culture Conditions | Ruite specialized complete Culture medium |
| THP-1 (human monocytic leukemia) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| 293T (human embryonic kidney cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HK-2 (human renal cortex proximal tubule epithelial cells) | Culture medium：90%DMEM/F12+10%FBS | Solid liquid separation type/liquid |
| Hep G2 (human hepatoblastoma cells) | Culture medium：90%RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| MRC-5 (human embryonic lung cells) | Culture medium: 90% MEM (including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SH-SY5Y (human neuroblastoma cells) | Culture medium：90%DMEM/F12+10%FBS | Solid liquid separation type/liquid |
| Caco-2 (human colorectal adenocarcinoma cells) | Culture medium：80% DMEM+20% FBS | Solid liquid separation type/liquid |
| A549(human lung adenocarcinoma cells) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| Jurkat, Clone E6‑1(human T-cell leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HuH-7 (human liver cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MCF7 (human breast cancer cell) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| Hela (human cervical cancer cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| LX-2 (human hepatic stellate cells) | Culture medium：90%DMEM/F12+10%FBS | Solid liquid separation type/liquid |
| HCT 116 (human colon cancer cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| PUMC-HUVEC-T1 (SV40T transformed human umbilical vein endothelial cells) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| AC16 (human myocardial cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| Hacat (human immortalized keratinocytes) | Culture medium：90%DMEM/F12+10%FBS | Solid liquid separation type/liquid |
| HT-29 (human colon cancer cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| PC-3 (human prostate cancer cells) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| HMC3 (human microglia) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| KGN (human ovarian granulosa cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| 293 [HEK-293] (human embryonic kidney cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| PANC‑1(human pancreatic cancer cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| WI‑38(human embryonic lung cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| U-87 MG (human glioblastoma cells) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| LNCaP clone FGC (human prostate cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A-375 (human malignant melanoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| U-2 OS (human osteosarcoma cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| Hep 3B2.1-7 (human liver cancer cells) | Culture medium: 90% MEM (including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SK-OV-3 (human ovarian cancer cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| AGS (human gastric adenocarcinoma cells) | Culture medium：90%RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| SK-BR-3 (human breast adenocarcinoma cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| U251 (human glioma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MH7A (human arthritis fibroblast) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| ARPE-19 (human retinal epithelial cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| BxPC-3 (human in situ pancreatic adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MDA ‑ MB ‑ 468 (human breast cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| GES-1 (human gastric mucosal cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| NCM460 (human normal colonic epithelial cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H1299 (human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| VCaP (human prostate cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HCE-T (human corneal epithelial cells) | Culture medium：85% DMEM/F12+15% FBS+5 μg/mL Insulin+10 ng/mL human EGF | Solid liquid separation type/liquid |
| Ishikawa (human endometrial cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| NCI-H1975 (human lung adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| PC-9 (human lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SW620 (human colon cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| K-562 (human chronic myeloid leukemia cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| Raji(human Burkitt&# x27; S lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| IMR‑90(human embryonic lung fibroblasts) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MKN‑45(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HTR-8 Svneo (human chorionic trophoblast cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| 22RV1 (human prostate cancer cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| SW480(human colon cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| CAL 27(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| RPMI 8226 (Peripheral Blood B Lymphocytes in Human Multiple Myeloma) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MM.1S (human multiple myeloma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HGC-27 (undifferentiated human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| EA.Hy926 (human umbilical vein cell fusion cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| MDA‑MB‑231(human breast cancer cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| AsPC-1 (human metastatic pancreatic adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC827(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| BT-474 (human breast ductal carcinoma cells) | Culture medium：80% RPMI‑1640+20% FBS+10 μg/mL Insulin+2 mM L‑glutamine | Solid liquid separation type/liquid |
| 12Z (immortalized human endometrial epithelial cells) | Culture medium：90% DMEM/F12(including HEPES)+10% FBS | Solid liquid separation type/liquid |
| 786-O (human renal clear cell adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SK-Hep-1 (human sinusoidal endothelial cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MIA PaCa‑2(human pancreatic cancer cells) | Culture medium：87.5% DMEM+10% FBS+2.5% HS | Solid liquid separation type/liquid |
| NALM-6 (human B-lymphoblastic leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| DU 145 (human prostate cancer cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| LoVo(human colon cancer cells) | Culture medium：90% Ham's F‑12K+10% FBS | Solid liquid separation type/liquid |
| NCI-H520 (human lung squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Nthy ori 3-1 (human thyroid normal cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NIH:OVCAR‑3(human ovarian cancer cells) | Culture medium：80% RPMI‑1640+20% FBS+10 μg/mL Insulin | Solid liquid separation type/liquid |
| Calu-3 (human lung adenocarcinoma cells (pleural effusion)) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| FaDu (human pharyngeal squamous cell carcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| T-47D (human breast ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS+10 μg/mL Insulin | Solid liquid separation type/liquid |
| NCI-H295R (human adrenal cortex adenocarcinoma cells) | Culture medium：90% DMEM/F12+10% FBS+0.5% ITS‑G(100×) | Solid liquid separation type/liquid |
| Ramos (human B lymphocyte tumor cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A549-DDP (human lung adenocarcinoma cisplatin resistant strain) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| TPC‑1(human thyroid cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| RPMI-2650 (human nasal epithelial cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| NCI-H660 (human neuroendocrine prostate cancer cells) | Culture medium：89.5% RPMI‑1640+10% FBS+0.5% ITS‑G+10 nM Hydrocortisone+10 nM β‑estradiol+2 mM L‑Glutamine | Solid liquid separation type/liquid |
| 293A (human embryonic kidney cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Caki-1 (human renal clear cell carcinoma skin metastatic cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| A-431 (human epidermal cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| BT-549 (human breast ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS+10 μg/mL Insulin | Solid liquid separation type/liquid |
| MG‑63(human osteosarcoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| 293FT (human embryonic kidney cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| LN229 (human glioblastoma cells) | Culture medium：95% DMEM+5% FBS | Solid liquid separation type/liquid |
| EOL-1 (human acute myeloid leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KYSE-150 (human esophageal squamous cell carcinoma cells) | Culture medium：44.5% RPMI‑1640+44.5% Ham& #x27; s F‑12+10% FBS | Solid liquid separation type/liquid |
| SV-HUC-1 (immortalized human ureteral epithelial cells) | Culture medium：90% Ham& #x27; s F‑12K+10% FBS | Solid liquid separation type/liquid |
| T24 (human bladder transitional cell carcinoma cells) | Culture medium：90%H-DMEM+10%FBS | Solid liquid separation type/liquid |
| U-937 (human histiocytic lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HTERT-HPNE (human normal pancreatic ductal cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HCC1937(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HEC-1-A (human endometrial adenocarcinoma cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| NCI‑N87(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| RBE (human cholangiocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCCLM3 (human highly metastatic liver cancer cells) | Culture medium：80% DMEM+20% FBS | Solid liquid separation type/liquid |
| NCI-H460 (large human cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| LS 174T(human colon adenocarcinoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| B-CPAP (human papillary thyroid carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| T98G (human glioma cells)) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SHP‑77(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HT-1080 (human fibrosarcoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| SiHa (human cervical squamous cell carcinoma cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| TF-1 (human leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS+2 ng/mL GM‑CSF | Solid liquid separation type/liquid |
| NCI-H929 (human myeloma cells) | Culture medium：90% RPMI‑1640+10% FBS+0.05 mM β‑mercaptoethanol | Solid liquid separation type/liquid |
| OVCAR‑8(human ovarian cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SUP-T1 (human T-cell lymphoblastic tumor cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| TMD8 (human diffuse large B-cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| ACHN(human renal cell adenocarcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MOLM‑13(human acute myeloid leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NPC/HK1(human nasopharyngeal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Eca‑109(human esophageal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| WPMY‑1(human normal prostate stromal immortalized cells) | Culture medium：95% DMEM+5% FBS | Solid liquid separation type/liquid |
| NCI‑H82(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MO3.13 (human oligodendrocytes) | Culture medium：80% DMEM+20% FBS | Solid liquid separation type/liquid |
| BPH -1 (human benign prostatic hyperplasia cells) | Culture medium：80% RPMI‑1640+20% FBS+20 ng/mL testosterone+0.5% ITS‑G(100×) | Solid liquid separation type/liquid |
| MEG-01 (human megakaryoblastic leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| OCI AML 3 (human acute myeloid leukemia cells) | Culture medium：85% IMDM+15% FBS | Solid liquid separation type/liquid |
| OS-RC-2 (human renal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H446(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| 293T/17 (human embryonic kidney cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| SK-MEL-28 (human malignant melanoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| HuCC-T1 (human cholangiocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Saos-2 (human osteosarcoma cells) | Culture medium：85% McCoy& #x27; s 5A+15% FBS | Solid liquid separation type/liquid |
| T84 (human colon adenocarcinoma lung metastasis cells) | Culture medium：95% DMEM/F12+5% FBS | Solid liquid separation type/liquid |
| HuT 78 (human T-cell leukemia cells) | Culture medium：80% IMDM+20% FBS | Solid liquid separation type/liquid |
| NCI‑H23(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| C-33A (human cervical cancer cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| NCI-H226 (human lung squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H358(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Bewo (human chorionic tumor cells) | Culture medium：85% Ham& #x27; s F‑12+15% FBS | Solid liquid separation type/liquid |
| NCI‑H69(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SU DHL 6 (human diffuse tissue lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC1954 (human breast ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| U266 (human multiple myeloma cells) | Culture medium：90% Advanced RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NB4 (human acute promyelocytic leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SU DHL 4 (human B lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC1806 (human breast squamous cell carcinoma) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HS-5 (human bone marrow stromal cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Mono‑Mac‑6(human acute monocytic leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS+10 μg/mL Insulin | Solid liquid separation type/liquid |
| YT (human NK cell leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MKN1(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| DLD-1 (human colorectal adenocarcinoma epithelial cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SCC-4 (human oral squamous cell carcinoma cells) | Culture medium：90% DMEM/F12+10% FBS+400 ng/mL Hydrocortisone | Solid liquid separation type/liquid |
| Capan‑1(human pancreatic cancer cells) | Culture medium：80% IMDM+20% FBS | Solid liquid separation type/liquid |
| NCI‑H196(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| U-2932 (human diffuse large B-cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H716 (human colorectal adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SK-N-BE (2) (human neuroblastoma cells) | Culture medium：90% MEM/F12+10% FBS | Solid liquid separation type/liquid |
| SK-MEL-5 (human skin melanoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| JIMT‑1(human breast cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HLE-B3 (human lens epithelial cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| 143B(human osteosarcoma cells) | Culture medium：90% MEM(ATCC modified)+10% FBS+0.015 mg/mL 5‑bromo‑2'‑deoxyuridine | Solid liquid separation type/liquid |
| 5637 (human bladder cancer cell) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KLE (human endometrial cancer cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| RD (malignant embryonic rhabdomyoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| SK-N-SH (human neuroblastoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| RT4 (human bladder transitional cell papilloma cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| UM-UC-3 (human bladder transitional cell carcinoma) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| NCI‑H441(human lung adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SCC‑25(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM/F12+10% FBS+400 ng/mL Hydrocortisone | Solid liquid separation type/liquid |
| SCC‑9(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM/F12+10% FBS+400 ng/mL Hydrocortisone | Solid liquid separation type/liquid |
| HPAF‑II(human pancreatic cancer cells) | Culture medium：90% MEM(ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| RKO(human colon adenocarcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| PLC/PRF/5 (human liver cancer Alexander cells) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| SW 1990(human pancreatic cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| COV434 (human ovarian granulosa tumor cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MV-4-11 (human myeloid monocytic leukemia cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| NCI‑H3122(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| OCI Ly3 (human diffuse large B-cell lymphoma cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| DMS 53 (human lung cancer cells) | Culture medium：90% Waymouth's MB 752/1+10% FBS | Solid liquid separation type/liquid |
| SRA01/04 (immortalized human lens epithelial cells) | Culture medium：80% DMEM+20% FBS | Solid liquid separation type/liquid |
| QGP‑1(human pancreatic cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| EBC-1 (human lung cancer squamous cell carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| IGROV‑1(human ovarian cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| LN-18 (human glioblastoma) | Culture medium：95% DMEM+5% FBS | Solid liquid separation type/liquid |
| OE33 (human esophageal adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A-673 (human rhabdomyosarcoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| CFPAC‑1(human pancreatic cancer cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| Daudi(human Burkitt&# x27; S lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCCC-9810 (human cholangiocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Hs 578T(human breast cancer cells) | Culture medium：90% DMEM+10% FBS+10 μg/mL Insulin | Solid liquid separation type/liquid |
| IMR-32 (human neuroblastoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| A172 (human glioblastoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HCT-8 (human ileocecal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HuH-6 (human hepatoblastoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| JeKo-1 (human mantle cell lymphoma cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| OMM-1 (human uveal melanoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| JEG-3 (human choriocarcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| TE‑1(human esophageal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A-498 (human renal cancer cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| IM-9 (human B lymphocytes) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KATO III(human gastric cancer cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| NCI-H2288 (human lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A549-TAX (paclitaxel resistant human lung adenocarcinoma cells) | Culture medium：90% Ham's F‑12K+10% FBS+1 μg/mL TAX | Solid liquid separation type/liquid |
| KYSE-410 (human esophageal squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HT ‑ 1376 (human bladder cancer cell) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| Capan‑2(human pancreatic cancer cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| MKN74(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Karpas-299 (human degenerative large cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KYSE-450 (human esophageal squamous cell carcinoma) | Culture medium：44.5% RPMI‑1640+44.5% Ham& #x27; s F‑12+10% FBS | Solid liquid separation type/liquid |
| A-427 (human lung cancer cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| BT‑20(human breast cancer cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| HS 683 (human glioma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| SW 1353 (human chondrosarcoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| TT (human medullary thyroid carcinoma cells) | Culture medium：90% Ham's F‑12K+10% FBS | Solid liquid separation type/liquid |
| PaTu 8988t(human pancreatic cancer cells) | Culture medium：90% DMEM+5% FBS+5% HS | Solid liquid separation type/liquid |
| SW872 (human liposarcoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| KYSE‑510(human esophageal cancer cells) | Culture medium：44.5% RPMI‑1640+44.5% Ham's F‑12+10% FBS | Solid liquid separation type/liquid |
| SUM149PT(human breast cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MEC-1 (human chronic B-cell leukemia cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| KMS 11 (Human Multiple Myeloma Clone Cell) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| GP2d(human colon cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| UPCI‑SCC‑090(human tongue squamous cell carcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| DoHH2 (human B-cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SKNO-1 (human acute myeloid leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS+10 ng/mL GM‑CSF | Solid liquid separation type/liquid |
| PSN1(human pancreatic cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| WI-38 VA-13 subline 2RA (human embryonic lung cell SV40 transformed into lung fibroblasts) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| LCL 721.221 (human B lymphocyte mother cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| OPM2 (human myeloma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| AN3 CA (human endometrial adenocarcinoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| MDA‑MB‑361(human breast cancer cells) | Culture medium：80% DMEM+20% FBS | Solid liquid separation type/liquid |
| MKN‑7(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SK-N-AS (human neuroblastoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| PC-9-DDP (cisplatin resistant human non-small cell lung cancer cell line) | Culture medium：90% RPMI‑1640+10% FBS+1 μg/mL DDP | Solid liquid separation type/liquid |
| LP-1 (human multiple myeloma cells) | Culture medium：90% IMDM+10% FBS | Solid liquid separation type/liquid |
| Ca Ski (human cervical cancer intestinal metastasis cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| CCRF-CEM (human acute lymphoblastic leukemia T lymphocytes) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| COLO 205(human colon cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| GBC-SD (human gallbladder cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCT-15 (human colorectal adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H292 (human lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| RL95-2 (human endometrial cancer cells) | Culture medium：95% DMEM/F12+5% FBS+5 μg/mL Insulin | Solid liquid separation type/liquid |
| SK-MES-1 (human lung squamous cell carcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| Caki-2 (human papillary renal cell carcinoma cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| HOS(human osteosarcoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MDA‑MB‑436(human breast cancer cells) | Culture medium：85% DMEM+15% FBS+10 μg/mL Insulin+16 μg/mL Glutathione | Solid liquid separation type/liquid |
| NCI-H2452 (human skin tumor cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SW 982 (human synovial sarcoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| U-118 MG (human glioblastoma) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| H4 (human glioma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HEC-1-B (human endometrial adenocarcinoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MDA‑MB‑453(human breast cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MOLT-4 (human acute lymphoblastic leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MET-5A (human epidermal cells) | Culture medium：90% M199+10% FBS+3.3 nM EGF+400 nM hydrocortisone+0.5% ITS‑G(100 ×) | Solid liquid separation type/liquid |
| M-07e (human giant cell leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS+8 ng/mL GM‑CSF | Solid liquid separation type/liquid |
| NTERA-2 (human malignant multiple teratoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| OE19(human esophageal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| T2 (human lymphoblasts) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SU.86.86 (human pancreatic ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A-253 (human submandibular gland epidermal cancer cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| NCI‑H526(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| MeWo (human malignant melanoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| HCC‑78(human lung adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SUIT‑2(human pancreatic cancer cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SW1573 (human alveolar carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Kelly (human neuroblastoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Calu-1 (human lung cancer cells) | Culture medium：90% McCoy's 5A+10% FBS | Solid liquid separation type/liquid |
| COLO 320DM (human colorectal adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| ES-2 (human ovarian clear cell carcinoma cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| NCI-H2171 (human lung cancer cells) | Culture medium：90% DMEM/F12+10% FBS+0.5% ITS‑G+10 nM Hydrocortisone+10 nM beta‑estradiol | Solid liquid separation type/liquid |
| LIM1215 (human colorectal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS+0.6 μg/mL Insulin | Solid liquid separation type/liquid |
| SSP-25 (human cholangiocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KYSE-270 (human esophageal squamous cell carcinoma cells) | Culture medium：44.5% RPMI‑1640+44.5% Ham& #x27; s F‑12+10% FBS | Solid liquid separation type/liquid |
| NCI‑H524(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| TE‑10(human esophageal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| OV‑90(human ovarian cancer cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| NCI-H1944 (human lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| DMS 114 (human lung cancer cells) | Culture medium：90% Waymouth's MB 752/1+10% FBS | Solid liquid separation type/liquid |
| 92-1 (human uveal melanoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SKM-1 (human acute myeloid leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| AU565(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC70 (human breast ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H522(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H2030(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KHYG-1 (human natural killer cell lymphoma leukemia) | Culture medium：90% RPMI‑1640+10% FBS+100 U/mL recombinant IL‑2 | Solid liquid separation type/liquid |
| Pfeiffer (human diffuse large B-cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KU ‑ 19 ‑ 19 (human bladder cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| C8166 (human T-cell leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Mino (human peripheral blood mantle cell lymphoma cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| MCF-12A (human mammary epithelial cells) | Culture medium：95% DMEM/F12+5% HS+20 ng/mL EGF+0.5 μg/mL Hydrocortisone+10 μg/mL Insulin+1% NEAA | Solid liquid separation type/liquid |
| WSU-HN30 (human oral squamous cell) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HuH‑1(human liver cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Dakiki (human B lymphocytes) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| AAV-293 (human embryonic kidney cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| J82 (human bladder transitional cell carcinoma) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| C918 (human choroidal melanoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| D283 Med (human medulloblastoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| HEL (Human Leukocyte Leukemia Cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H2170 (human lung squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SW 780 (human bladder transitional cell carcinoma) | Culture medium：90% Leibovitz& #x27; s L‑15+10% FBS | Solid liquid separation type/liquid |
| A-204 (human rhabdomyosarcoma cells) | Culture medium：90% McCoy& #x27; s 5A+10% FBS | Solid liquid separation type/liquid |
| SW48(human colon adenocarcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| KYSE-30 (human esophageal squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+Ham& #x27; s F‑12+2 mM L‑glutamine+10% FBS | Solid liquid separation type/liquid |
| SUM159PT (human breast cancer cell line) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KTC‑1(human thyroid cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| A2058 (human skin cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HCC1428 (human breast adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| IOMM Lee (human meningioma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| NCI‑H1650(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| ZR‑75‑1(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Jurkat clone A3 (human T-cell leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SU-DHL-1 (human degenerative large cell lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NUGC‑3(human gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC1143(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| CCRF-SB (human peripheral blood lymphocytes) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KYSE-140 (human esophageal squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCC1569(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HCT-15-5FU (human colorectal cancer fluorouracil resistant strain) | Culture medium：90% RPMI‑1640+10% FBS+20 μg/mL 5‑FU | Solid liquid separation type/liquid |
| KPL‑4(human breast cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| COV362(human ovarian cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Kuramochi(human ovarian cancer cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| ECC12 (human small cell gastric cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| BV-173 (human leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| KM12(human colon cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Caov-3 (human mammary gland adenocarcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| CoC1 DDP (human ovarian cancer cell line CoC1 cisplatin resistant subtype) | Culture medium：90% RPMI‑1640+10% FBS+0.5‑2 μg/mL DDP | Solid liquid separation type/liquid |
| SK-LU1 (human poorly differentiated lung adenocarcinoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| SW1463 (human colon cancer cells) | Culture medium：90% Leibovitz& #x27; s L‑15+10% FBS | Solid liquid separation type/liquid |
| SU DHL 2 (human diffuse tissue lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H1573 (human lung cancer adenocarcinoma cells) | Culture medium：95% RPMI‑1640+5% FBS | Solid liquid separation type/liquid |
| SACC-83 (human salivary gland adenoid cystic carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HPAC (human pancreatic acinar epithelial carcinoma) | Culture medium：95% DMEM/F12+5% FBS+0.5% ITS‑G+40 ng/mL Hydrocortisone+10 ng/mL EGF | Solid liquid separation type/liquid |
| MS751 (human cervical epidermal cancer cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| NCI-H1703 (human lung squamous cell carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI-H596 (human lung adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H838(human non-small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| PA-1 (human ovarian teratoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SW-13 (human adrenal cortex small cell carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Farage (human B lymphoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Daoy(human medulloblastoma cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| NCI-H647 (human lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| LS513 (human colorectal cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| FTC-133 (human follicular thyroid cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| RT ‑ 112 (human bladder cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| HuP-T3 (human pancreatic adenocarcinoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| 769‑P(human renal cell adenocarcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| 95-D (human highly metastatic lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| JAR (human placental villous carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| JHH‑7(human liver cancer cells) | Culture medium：90% DMEM/F12+10% FBS | Solid liquid separation type/liquid |
| HT ‑ 1197 (human bladder cancer cell) | Culture medium：90% MEM(including NEAA)+10% FBS+1 mM Sodium Pyruvate | Solid liquid separation type/liquid |
| NCI-H1666 (human lung bronchial cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NOMO-1 (human leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| SW1783 (human glioblastoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| HCC1187 (human breast ductal carcinoma cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Lu-65 (large human cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| NCI‑H187(human small cell lung cancer cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| REC-1 (human non Hodgkin lymphoma cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| MP38 (human uveal melanoma cells) | Culture medium：80% RPMI‑1640+20% FBS | Solid liquid separation type/liquid |
| TR-LCC-1 (human laryngeal cancer cells) | Culture medium：85% RPMI‑1640+15% FBS | Solid liquid separation type/liquid |
| OCI‑AML‑2(human acute myeloid leukemia cells) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| Granta-519 (human B-cell lymphoma) | Culture medium：90% RPMI‑1640+10% FBS | Solid liquid separation type/liquid |
| WSU‑HN6(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| KMRC-1 (human renal clear cell carcinoma cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| Hela S3 (human cervical cancer cells) | Culture medium：90% Ham's F-12K+10% FBS | Solid liquid separation type/liquid |
| HuTu-80 (human duodenal adenocarcinoma) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| MDA-MB-175VII (human breast ductal carcinoma cells) | Culture medium：90% Leibovitz& #x27; s L-15+10% FBS | Solid liquid separation type/liquid |
| NCI-H596 (human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| SF126 (human brain tumor cells) | Culture medium：90% MEM(including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SNU-1(human gastric cancer cells) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| SW837 (human colorectal adenocarcinoma cells) | Culture medium：90% Leibovitz& #x27; s L-15+10% FBS | Solid liquid separation type/liquid |
| SW837 (human colorectal adenocarcinoma cells cultured in DMEM) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| MDA-MB-361(human breast cancer cells) | Culture medium：80% Leibovitz& #x27; s L-15+20% FBS | Solid liquid separation type/liquid |
| BALL-1 (human B lymphocyte acute leukemia) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| NCCIT (Human Fetal Cancer Cells) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| Hey(human ovarian cancer cells) | Culture medium：90% DMEM+10% FBS | Solid liquid separation type/liquid |
| AMO1 (human multiple myeloma cells) | Culture medium：80% RPMI-1640+20% FBS | Solid liquid separation type/liquid |
| NCI-H146(human small cell lung cancer cells) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| ARH-77 (human plasma cell leukemia) | Culture medium：90% RPMI-1640+10% FBS | Solid liquid separation type/liquid |
| SU-DHL-1 (human B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| KYSE-180 (human esophageal squamous cell carcinoma) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1666 (human lung bronchial cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SK-N-DZ (human neuroblastoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1793 (human lung cancer cells) | Culture medium：90% DMEM/F12 + 10% FBS + 0.5% ITS-G + 10 nM Hydrocortisone + 10 nM beta-estradiol | Solid liquid separation type/liquid |
| SK-GT-4 (human esophageal cancer tumor cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| WM-266-4 (human melanoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| CAL-33(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM + 10% FBS + 2 mM L-Glutamine | Solid liquid separation type/liquid |
| SNU-601(human gastric cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| REC-1 (human non Hodgkin lymphoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| MEL270 (human choroidal melanoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| SK-ES-1(human osteosarcoma cells) | Culture medium：90% McCoy's 5A + 10% FBS | Solid liquid separation type/liquid |
| GCIY(human gastric cancer cells) | Culture medium：85% DMEM + 15% FBS | Solid liquid separation type/liquid |
| CCF-STTG1 (Human Brain Astrocytoma Cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1781 (human bronchiolar alveolar carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| WIL2S (human B lymphocytes) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| BFTC-905 (human bladder transitional cell carcinoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| Panc 02.13(human pancreatic cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS + 10 μg/mL Insulin | Solid liquid separation type/liquid |
| THP-1-GFP (human monocytic leukemia labeled with green fluorescent protein) | Culture medium：90% RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| AMC-HN-8 (human laryngeal cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HMy2-CIR (human B lymphoblasts) | Culture medium：90% IMDM + 10% FBS | Solid liquid separation type/liquid |
| HuT 102 (human T-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS + 100-200 U/mL recombinant IL-2 | Solid liquid separation type/liquid |
| Li-7(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| A875 (human melanoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| SW1116 (human colon adenocarcinoma cells cultured in DMEM) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| CEM/C1 (human acute lymphoblastic leukemia cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| G-401 (human renal cancer Wilms cells) | Culture medium：90% McCoy& #x27; s 5A + 10% FBS | Solid liquid separation type/liquid |
| NCI-H157 (human non-small cell lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SK-CO-1 (human colorectal adenocarcinoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| SW-13 (human adrenal cortex small cell carcinoma) | Culture medium：90% Leibovitz& #x27; s L-15 + 10% FBS | Solid liquid separation type/liquid |
| WERI-Rb-1 (human retinoblastoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| Reh (acute non-B non-T lymphocytic leukemia) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MHCC97-L (human low metastatic liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| H9 (human T lymphocyte line) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| JVM-2 (EB virus infected human peripheral lymphocytes) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MC/CAR (human peripheral blood lymphocytes) | Culture medium：80% IMDM + 20% FBS | Solid liquid separation type/liquid |
| DMS 153 (Human Small Cell Lung Cancer) | Culture medium：90% Waymouth& #x27; s MB 752/1 + 10% FBS | Solid liquid separation type/liquid |
| BHT101(undifferentiated human thyroid cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| TCCSUP (human bladder cancer cell) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| SW948 (human colon adenocarcinoma cells cultured in DMEM) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| C643(human thyroid cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MT-4 (human T-cell leukemia cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1568(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SJSA-1(human osteosarcoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SK-MEL-2 (human skin melanoma cells) | Culture medium：90% DMEM/F12 + 10% FBS | Solid liquid separation type/liquid |
| Malme-3M (human malignant melanoma cells) | Culture medium：80% IMDM + 20% FBS | Solid liquid separation type/liquid |
| SN12C (human renal cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| HKb20 (human renal epithelial cells) | Culture medium：90% DMEM + 10% FBS + 800 μg/mL G-418 | Solid liquid separation type/liquid |
| ARD (Human Multiple Myeloma Cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SW756 (human uterine squamous cell carcinoma) | Culture medium：90% Leibovitz& #x27; s L-15 + 10% FBS | Solid liquid separation type/liquid |
| IHH-4 (human papillary thyroid carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| Panc 03.27(human pancreatic cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS + 10 μg/mL Insulin | Solid liquid separation type/liquid |
| TK6 (human lymphocyte) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SW1417 (human colorectal adenocarcinoma cells) | Culture medium：90% Leibovitz& #x27; s L-15 + 10% FBS | Solid liquid separation type/liquid |
| SU-DHL-8 (human B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HSC-2 (human oral squamous cell carcinoma) | Culture medium：90% DMEM/F12 + 10% FBS | Solid liquid separation type/liquid |
| LS180(human colon cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2444(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| UM-SCC-1 (Population based squamous cell carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1792(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| WM115 (human malignant melanoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1993 (human non-small cell lung cancer adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SNU-449(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| PK-59 (human pancreatic cancer epithelial cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| UM-Chor1 (human mesangial cells) | Culture medium：71.2% IMDM + 17.8% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| LAMA-84 (human chronic myeloid leukemia cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| CHP-212 (human brain neuroblastoma) | Culture medium：90% MEM/F12 + 10% FBS | Solid liquid separation type/liquid |
| SK-UT-1 (human uterine leiomyosarcoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| SK-LMS-1 (human leiomyosarcoma cells) | Culture medium：90% MEM(ATCC modified) + 10% FBS | Solid liquid separation type/liquid |
| SBC-3(human small cell lung cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| Hep G2-LUC-EGFP (human hepatoblastoma cells labeled with green fluorescent enzyme) | Culture medium：90% RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| K-562-GFP (human chronic myeloid leukemia cells (green fluorescent marker)) | Culture medium：90% RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| TE-14 (human esophageal squamous cell carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| U-87 MG-GFP (human glioblastoma cells labeled with green fluorescence) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| P3HR-1 (human B lymphoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| LCLC-97TM1 (human lung cancer cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| HT-29-ADR (human colon cancer cell line resistant to doxorubicin) | Culture medium：90% McCoy's 5A + 10% FBS + 0.8 μg/mL ADR | Solid liquid separation type/liquid |
| COV644(human ovarian cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| COR-L23 (large human cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| CMK (human acute megakaryocytic leukemia cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-231-LUC (human breast cancer cells (labeled with luciferase)) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| 8505C(human thyroid cancer cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| NAMALWA(human Burkitt&# x27; S lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| COLO 201 (human colorectal adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| CW-2(human colon adenocarcinoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1395(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HCC 94 (human uterine squamous cell carcinoma cells (highly differentiated)) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H661 (large human cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| 293E (human embryonic kidney cells (EBNA1 gene modified)) | Culture medium：90% IMDM + 10% FBS | Solid liquid separation type/liquid |
| 2V6.11 (human embryonic kidney cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| Detroit 562 (human pharyngeal cancer pleural fluid metastatic cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-175VII (human breast ductal carcinoma cells cultured in DMEM) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-415(human breast cancer cells) | Culture medium：85% Leibovitz's L-15 + 15% FBS + 10 μg/mL Insulin + 16 μg/mL Glutathione | Solid liquid separation type/liquid |
| NCI-H2087 (human non-small cell lung adenocarcinoma cells) | Culture medium：95% RPMI-1640 + 5% FBS | Solid liquid separation type/liquid |
| NCI-H209(human small cell lung cancer cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| Sc-1 (human B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SK-MEL-1 (human skin melanoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| JM (human T-cell leukemia cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2347 (human lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SNU-387(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| CAL-62(undifferentiated human thyroid cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| KHM-5M(undifferentiated human thyroid cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SW948(human colon adenocarcinoma cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| HT-3 (human cervical cancer cells) | Culture medium：90% McCoy& #x27; s 5A + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1437 (human lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| Hela 229 (human cervical cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2126 (human lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1755 (human lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| KHOS-240S(human osteosarcoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| HMY-1 (human melanoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| SW620-LUC (human colon cancer cells labeled with luciferase) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| MDA-kb2(human breast cancer cells (DMEM culture) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| Panc 10.05(human pancreatic cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS + 10 μg/mL Insulin | Solid liquid separation type/liquid |
| SK-LU-1 (human poorly differentiated lung adenocarcinoma cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| DU4475 (human mammary epithelial cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HARA-B (human lung squamous cell carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| A-704 (human kidney cancer cells) | Culture medium: 90% MEM (ATCC modified)+10% FBS | Solid liquid separation type/liquid |
| HCC4006(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2009(human lung adenocarcinoma cells) | Culture medium：90% DMEM/F12 + 10% FBS | Solid liquid separation type/liquid |
| Panc 08.13(human pancreatic cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS + 10 μg/mL Insulin | Solid liquid separation type/liquid |
| SW1710 (human bladder cancer cell) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| SNU-16(human gastric cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| Jiyoye (human B lymphocytes) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SAS (human tongue squamous cell carcinoma) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| SW900 (human lung cancer squamous cell carcinoma cells) | Culture medium：90% Advanced DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2122 (human lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SW1271(human small cell lung cancer cells) | Culture medium：80% Leibovitz's L-15 + 20% FBS | Solid liquid separation type/liquid |
| Marcus (human astrocytoma) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MES-SA (human uterine sarcoma cells) | Culture medium：90% McCoy& #x27; s 5A + 10% FBS | Solid liquid separation type/liquid |
| MFE-280 (human endometrial adenocarcinoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| HCC1833(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1915(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H3255 (human lung cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS | Solid liquid separation type/liquid |
| COLO-680N (human esophageal squamous cell carcinoma) | Culture medium：90% RPMI-1640 + 10% FBS + 10 ng/mL GM-CSF | Solid liquid separation type/liquid |
| CL-11(human colon cancer cells) | Culture medium：80% DMEM/F12(including HEPES) + 20% FBS | Solid liquid separation type/liquid |
| Z-138 (human mantle cell lymphoma cells) | Culture medium：90% IMDM + 10% HS | Solid liquid separation type/liquid |
| GCT (human giant cell tumor cells) | Culture medium：90% McCoy& #x27; s 5A + 10% FBS | Solid liquid separation type/liquid |
| MP41 (human uveal melanoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| A549-GFP (human lung adenocarcinoma cells labeled with green fluorescent protein) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| NCI-H1417(human small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MOG-G-UVW (Human Brain Astrocytoma Cells) | Culture medium：90% DMEM/F12(including HEPES) + 10% FBS | Solid liquid separation type/liquid |
| SW962 (human vaginal phosphorus cancer cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| SW962 (human vulvar phosphocarcinoma cells cultured in DMEM) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| ST486(human Burkitt&# x27; S lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| GLAG-66(human thyroid cancer cells) | Culture medium：90% Ham& #x27; s F-12K + 10% FBS | Solid liquid separation type/liquid |
| Hep G2-GFP (human hepatoblastoma cells labeled with green fluorescent protein) | Culture medium：90% RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| U-2 OS-LUC-EGFP (human osteosarcoma cells labeled with green fluorescent luciferase) | Culture medium：90% McCoy& #x27; s 5A + 10% FBS | Solid liquid separation type/liquid |
| PC-3-LUC-EGFP (human prostate cancer cells labeled with luciferase green fluorescence) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| MCF7-LUC-EGFP (human breast cancer cells (luciferase green fluorescent labeling)) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| HCT 116-GFP (human colon cancer cells labeled with green fluorescence) | Culture medium：90% McCoy's 5A + 10% FBS | Solid liquid separation type/liquid |
| HuH-7.5.1(human liver cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| IM95m(human gastric adenocarcinoma cells) | Culture medium：90% DMEM + 10 μg/mL Insulin + 10% FBS | Solid liquid separation type/liquid |
| HCC2935(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| OVCAR-5(human ovarian cancer cells) | Culture medium：90% M199 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H446-LUC-EGFP(Human small cell lung cancer cells (labeled with green fluorescent luciferase) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| KNS-62(human lung bronchial squamous cell carcinoma) | Culture medium：80% MEM(ATCC modified) + 20% FBS | Solid liquid separation type/liquid |
| HH(human skin T lymphocyte tumor cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| VMRC-RCZ(human renal cell carcinoma cells) | Culture medium：80% MEM(ATCC modified) + 20% FBS | Solid liquid separation type/liquid |
| UPCI-SCC-154(human tongue squamous cell carcinoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| AHH-1(Peripheral blood B lymphocytes) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| DMS 79(human small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2110(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H2052(human lung mesothelioma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HDQ-P1(human breast cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| OAW28(human ovarian epithelial tumor cells) | Culture medium：90% DMEM + 10 μg/mL Insulin + 10% FBS | Solid liquid separation type/liquid |
| A549-LUC(human lung adenocarcinoma cells labeled with luciferase) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| Angine(human ovarian cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| CA46(human Burkitt&# x27; S lymphoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| CCD-1095Sk(Skin cells adjacent to invasive ductal carcinoma of the human breast) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| HBL-100(breast epithelial cells integrating SV40 gene in humans) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HuH-6(human hepatoblastoma cells (William's E culture) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| SW579(human thyroid squamous cell carcinoma cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| SW579(human thyroid squamous cell carcinoma cells (DMEM culture)) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| SW1116(human colon adenocarcinoma cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| EB-3(human Burkitt&# x27; S lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| Hce-8693(undifferentiated human cecal adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-415(human breast cancer cells (DMEM culture) | Culture medium：85% DMEM + 10 μg/mL Insulin + 10 μg/mL Glutathione + 15% FBS | Solid liquid separation type/liquid |
| RKO-AS45-1(transgenic human colon cancer cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| RKO-E6(transgenic human colon cancer cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| SF763(human brain cancer cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| SK-NEP-1(human nephroblastoma cells) | Culture medium：90% McCoy's 5A + 10% FBS | Solid liquid separation type/liquid |
| SK-N-MC(human neuroepithelial tumor cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| MNNG/HOS Cl #5(human osteosarcoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| HAL-01(human lymphocytic leukemia cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SNU-182(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| KMH-2(undifferentiated human thyroid cancer cells) | Culture medium：44.5% DMEM + 44.5% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-231-GFP(Human breast cancer cells (labeled with green fluorescent protein) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1563(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| ACT-1(human thyroid cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| CX-1(human colon cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| TTA1(human thyroid cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| D341Med(human medulloblastoma cells) | Culture medium：90% MEM(ATCC modified) + 10% FBS + 1 mM Sodium Pyruvate | Solid liquid separation type/liquid |
| U-2 OS-GFP(human osteosarcoma cells (labeled with green fluorescent protein) | Culture medium：90% McCoy's 5A + 10% FBS | Solid liquid separation type/liquid |
| ACHN-GFP(human renal cell adenocarcinoma cells (green fluorescent marker)) | Culture medium: 90% MEM (including NEAA)+10% FBS | Solid liquid separation type/liquid |
| SW620-GFP(human colon cancer cells labeled with green fluorescent protein) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| MDA-kb2(human breast cancer cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| BC-3(human lymphoma cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| A-431-LUC(human skin squamous cell carcinoma cells (labeled with luciferase)) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| Panc 05.04(human pancreatic cancer cells) | Culture medium：85% RPMI-1640 + 10 μg/mL Insulin + 15% FBS | Solid liquid separation type/liquid |
| Mahlavu(human liver cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| SNU-216(human gastric cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| TE-12(human esophageal cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1648(human lung adenocarcinoma cells) | Culture medium：95% RPMI-1640 + 5% FBS | Solid liquid separation type/liquid |
| SW756(human uterine squamous cell carcinoma cells (DMEM culture)) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| HTh83(human thyroid cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| OCUT-2C(undifferentiated human thyroid cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| NCI-BL2009(human lymphoblastic cells (EBV transformation)) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HCC38 BL(human lymphoblastic cells (EBV transformation)) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SW1710(human bladder cancer cells (DMEM culture) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| LK-2(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| SVCT(human mammary epithelial cells) | Culture medium：90% DMEM + 5 μg/mL Hydrocortisone + 10 μg/mL Insulin + 10% FBS | Solid liquid separation type/liquid |
| SW900(human lung cancer squamous cell carcinoma cells (L15 culture)) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1693(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HS-27A(human bone marrow cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| TOLEDO(human diffuse large B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HCC1588(human lung squamous cell carcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MDA-MB-134-VI(human breast ductal carcinoma cells cultured in DMEM) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| OAW42(human ovarian cancer cells) | Culture medium：90% DMEM + 10 μg/mL Insulin + 10% FBS | Solid liquid separation type/liquid |
| SW1088(human Brain Astrocytoma Cells) | Culture medium：90% Leibovitz's L-15 + 10% FBS | Solid liquid separation type/liquid |
| HT-29-GFP(human colorectal adenocarcinoma cells labeled with green fluorescent protein) | Culture medium：RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| SNU-C5(human colorectal adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| VMM39(human melanoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| JM-1(human B lymphoblastic tumor cells) | Culture medium：90% IMDM + 0.05 mM β-mercaptoethanol + 10% FBS | Solid liquid separation type/liquid |
| MUG-Chor1(human low spinal cord tumor cells) | Culture medium：80% IMDM + 20% FBS | Solid liquid separation type/liquid |
| PC-3-GFP(human prostate cancer cells (green fluorescent marker)) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| PC-3-RFP(human prostate cancer cells (red fluorescent marker)) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| HCT-15-TAX(paclitaxel resistant strain of human colon adenocarcinoma) | Culture medium：90% RPMI-1640 + 10% FBS + 1 μg/mL TAX | Solid liquid separation type/liquid |
| MCF-7-FLUC(human breast cancer cells (FLUC labeled)) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| LC-2/ad(human lung adenocarcinoma cells) | Culture medium：44.5% RPMI-1640 + 44.5% Ham's F-12 + 10% FBS | Solid liquid separation type/liquid |
| SNU-398(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MCF-7-GFP(human breast cancer cells (labeled with green fluorescent protein) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| SNU-475(human liver cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| AGS-LUC-EGFP(human gastric adenocarcinoma cells (green fluorescent labeled with luciferase) | Culture medium：90%RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| AGS-GFP(human gastric adenocarcinoma cells (green fluorescent marker)) | Culture medium：90% RPMI 1640+10%FBS | Solid liquid separation type/liquid |
| U-87-GFP(human Tissue Cell Lymphoma Cells (Green Fluorescent Label)) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| C99(human colon adenocarcinoma cells) | Culture medium：80% IMDM + 20% FBS | Solid liquid separation type/liquid |
| COLO 699(human melanoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| CCK-81(human colon adenocarcinoma cells) | Culture medium：90% MEM(ATCC modified) + 10% FBS | Solid liquid separation type/liquid |
| GM23688(human Myeloid Muscular Atrophy Lymphocytes) | Culture medium：85% RPMI-1640 + 15% FBS | Solid liquid separation type/liquid |
| GM23687(human Myeloid Muscular Atrophy Lymphocytes) | Culture medium：85% RPMI-1640 + 15% FBS | Solid liquid separation type/liquid |
| GM23255(human Myeloid Muscular Atrophy Lymphocytes) | Culture medium：85% RPMI-1640 + 15% FBS | Solid liquid separation type/liquid |
| NCI-H446-GFP(human small cell lung cancer cells (green fluorescent marker)) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| A101D(human melanoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H322(human bronchial lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| HCC827-ADR(human non-small cell lung cancer cell line resistant to doxorubicin) | Culture medium：90% RPMI-1640 + 10% FBS + 0.5 μg/mL ADR | Solid liquid separation type/liquid |
| NCI-BL1437(human lymphoblastic cells (EBV transformation)) | Culture medium：90% DMEM/F12 + 0.5% ITS-G + 10 nM beta-estradiol + 10% FBS | Solid liquid separation type/liquid |
| RC-K8(human diffuse large B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| PC-3-LUC(human prostate cancer cells labeled with luciferase) | Culture medium：90% H-DMEM+10%FBS | Solid liquid separation type/liquid |
| NCI-H1623(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1651(human lung adenocarcinoma cells) | Culture medium：90% DMEM/F12(including HEPES) + 0.5% ITS-G + 50 nM Hydrocortisone + 0.01 mM ethanolamine + 0.01 mM
phosphorylethanolamine + 0.5 mM sodium pyruvate + 2 mM L-Glutamine + 100 pM
triiodothyronine + 10%
FBS | Solid liquid separation type/liquid |
| NCI-H1838(human lung adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| CAL-12T(human non-small cell lung cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| HuG1-N(human gastric tubular adenocarcinoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H1581(human non-small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H211(human small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| NCI-H889(human small cell lung cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| RL(human B-cell lymphoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| COLO 678(human colon cancer cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
| MFE-296(human endometrial adenocarcinoma cells) | Culture medium：39.25% RPMI-1640 + 39.25% MEM(ATCC modified) + 20% FBS + 2 mM L-Glutamine + 0.5% ITS-G | Solid liquid separation type/liquid |
| U-CH1(human sacral chordoma cells) | Culture medium：80% IMDM + 20% RPMI-1640 + 10% FBS + 2 mM L-glutamine | Solid liquid separation type/liquid |
| NCI-H2172(human non-small cell lung cancer cells) | Culture medium：90%RPMI-1640 +10% FBS | Solid liquid separation type/liquid |
| UACC-62(human melanoma cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| ABC-1(human lung adenocarcinoma cells) | Culture medium：90% MEM(including NEAA) + 10% FBS | Solid liquid separation type/liquid |
| CAL-148(human breast cancer cells) | Culture medium：90% DMEM + 10% FBS | Solid liquid separation type/liquid |
| COLO 824(human breast cancer cells) | Culture medium：85% RPMI-1640 + 15% FBS | Solid liquid separation type/liquid |
| NCI-H1048(human small cell lung cancer cells) | Culture medium：90% DMEM/F12 + 0.5% ITS-G + 10 nM Hydrocortisone + 10 nM beta-estradiol + 10% FBS | Solid liquid separation type/liquid |
| MT-2(human umbilical cord white blood cells) | Culture medium：80% RPMI-1640 + 20% FBS | Solid liquid separation type/liquid |
| ONS-76(human medulloblastoma cells) | Culture medium：90% RPMI-1640 + 10% FBS | Solid liquid separation type/liquid |
